A major effort to get a biomedical research bill across the finish line in Congress has stalled, despite protestations of “momentum” for the far-reaching measure.

The House passed the 21st Century Cures Act nearly a year ago, and House leaders have continued to work for its passage in the Senate, but its efforts have been in vain. The bill seeks to hasten approval of new drugs and devices and provides new money for medical research.